Effectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis: A 104-week pilot study

The aim of this study was to evaluate clinical efficacy of telbivudine in treatment of hepatitis B virus-associated glomerulonephritis (HBV-GN). A total of 43 HBV-GN patients combined with chronic hepatitis B were treated with telbivudine for 104 weeks. Serum levels of HBV DNA viral load, HBeAg, HBe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zhaoping, Qiao, Bing, Zhang, Haifeng, Wang, Yanling, Gou, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081091/
https://www.ncbi.nlm.nih.gov/pubmed/30075577
http://dx.doi.org/10.1097/MD.0000000000011716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081091/
https://www.ncbi.nlm.nih.gov/pubmed/30075577
http://dx.doi.org/10.1097/MD.0000000000011716

Ejemplares similares